hmm competing in a market of annual sales of $US21 - wonder if thats why SP has dipped on the ANN. Competitors already there so what incentive os there for the marketers to drive sales in such a small market - what are the costs associated with marketing/commissions etc - did i miss that?. all imo.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux receives third FDA ANDA approval
Ann: Acrux receives third FDA ANDA approval, page-4
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M |
Open | High | Low | Value | Volume |
6.3¢ | 6.3¢ | 6.0¢ | $9.242K | 150.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 72503 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 4393 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 72503 | 0.063 |
1 | 7903 | 0.062 |
3 | 39326 | 0.060 |
1 | 20000 | 0.059 |
3 | 60723 | 0.058 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 4393 | 1 |
0.066 | 51620 | 2 |
0.067 | 46144 | 4 |
0.068 | 50000 | 1 |
0.069 | 14507 | 1 |
Last trade - 12.51pm 16/08/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |